Your browser doesn't support javascript.
loading
Patient-Reported Symptom Burden and Supportive Care Needs of Patients With Stage II-III Colorectal Cancer During and After Adjuvant Systemic Treatment: A Real-World Evidence Study.
Cuthbert, Colleen A; O'Sullivan, Dylan E; Boyne, Devon J; Brenner, Darren R; Cheung, Winson Y.
Affiliation
  • Cuthbert CA; Faculty of Nursing, University of Calgary, Calgary, Alberta, Canada.
  • O'Sullivan DE; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Boyne DJ; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Brenner DR; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Cheung WY; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
JCO Oncol Pract ; 19(3): e377-e388, 2023 03.
Article in En | MEDLINE | ID: mdl-36608313
ABSTRACT

PURPOSE:

Patients with colorectal cancer (CRC) experience a range of physical and psychologic symptoms, and supportive care needs throughout the illness trajectory. We used patient-reported outcomes and administrative health data to describe symptom burden and supportive care needs during and after adjuvant treatment and determine factors associated with changes to symptom burden.

METHODS:

A retrospective population-based cohort study of patients who were newly diagnosed with stage II-III CRC in Alberta, Canada, between January 1, 2016, and January 31, 2019. Adults age 18 years or older who completed a patient-reported outcomes survey (Edmonton Symptom Assessment System) and supportive care needs (Canadian Problem Checklist) within 3 months after starting adjuvant treatment (during treatment) and > 7 months after starting treatment (after treatment) were included. Changes to symptom severity were stratified as stable, improved, or deteriorated. Multivariable logistic regression was used to evaluate factors associated with these changes.

RESULTS:

We included 303 patients (median age 60 years, 62% male, 84.5% stage III, 51.2% rectal v colon). Prevalent symptoms included tiredness (80.5%), pain (50.8%), and poor well-being (50%) during treatment, and tiredness (71.3%), pain (44.2%), and poor well-being (62.1%) after treatment. The results were heterogeneous with respect to improvements, stability, or deterioration. Pain worsened for 25% of the cohort, tiredness for 28%, and depression, anxiety, and well-being for 21%, 22%, and 31%, respectively. Deterioration of some symptoms was associated with older age, stage II, comorbidities, rural setting, and higher income.

CONCLUSION:

We demonstrated symptom severity was generally low and most symptoms remained stable or improved after treatment. Particular groups of patients were at greater risk for more severe and/or more persistent symptoms. Ongoing assessments and interventions to address physical and psychologic symptoms, and supportive care needs in patients with CRC during and after treatment are needed.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: JCO Oncol Pract Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: JCO Oncol Pract Year: 2023 Document type: Article